XLON
IPO
Market cap769mUSD
Jul 09, Last price
64.90GBP
1D
2.20%
1Q
18.65%
Jan 2017
-63.70%
IPO
-5.72%
Name
IP Group PLC
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
IP Group Plc functions as a private equity and venture capital enterprise, allocating funds across the entire lifecycle of businesses, from initial seed and early-stage rounds to start-up, incubation, growth capital, and mature financing. A specific focus includes providing seed funding for new ventures spun out from academic institutions. The firm's investment interests are broad, encompassing sectors such as life sciences, physical sciences, energy and renewable technologies, medical devices and supplies, general healthcare, technology, cleantech, intellectual property, pharmaceuticals and biotechnology, information technology and communications, and chemicals and materials. Furthermore, it assists its university collaborators with the identification and subsequent commercialization of intellectual property. Individual investments typically range between £0.5 million and £1 million (or $0.75 million and $1.50 million), with a preference for securing equity stakes in its portfolio companies. Established in 2001, IP Group Plc is based in London, United Kingdom, and maintains a global footprint with additional offices in Wilmington, Delaware; Oxford, United Kingdom; Hong Kong S.A.R.; and Melbourne, Australia.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||